Biomedical Research Company for Sale
Established Biomedical Research Lab with 75% Net Margin
On NextCompany since August 27, 2026 (today)
Location undisclosed
Business overview
The biomedical research company serves over 850 clients globally. It delivers genomic profiling and molecular diagnostics to academic centers and biotech firms. The lab holds CAP accreditation and CLIA certification. Revenue has averaged over $5 million annually for 25 years. The owner pursues the sale to focus on other ventures.
Who is a good fit for this business
- Strategic buyers in biomedical research or diagnostics sectors.
- Acquirers seeking a lab with 850-plus clients and high margins.
- Investors open to owner transition support or consulting arrangements.
Details
- Reason for selling
- The current owner is pursuing the sale to concentrate on other business ventures.
Frequently Asked Questions
The company offers global genomic profiling and molecular diagnostics. Work covers Problem Definition, Project Design, and Data Discovery stages. Clients include academic centers, pharmaceutical firms, oncologists, and pathologists.
Revenue has averaged over $5 million per year for the past 25 years. The net profit margin reaches 75 percent. The lab maintains more than 850 clients with 55 percent academic and 40 percent biotech referrals.
The current owner pursues the sale to concentrate on other business ventures. The owner will support transition and may remain as consultant or part-time employee if needed.